Status:
COMPLETED
Computerized Facial Recognition for Automated Diagnosis of the Facio-Scapulo-Humeral Muscular Dystrophy (FSMHD)
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Facio-Scapulo-Humeral Dystrophy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The clinical diagnosis of Facio-Scapulo-Humeral Muscular Dystrophy (FSHMD) requires the movement of patients to a medical centre and a lengthy examination involving medical personnel, and may be under...
Eligibility Criteria
Inclusion
- \- Patient belonging to one of these four groups:
- Group 1 FSMHD confirmed or to be confirmed with moderate facial involvement
- Group 2 FSMHD confirmed or to be confirmed with severe facial involvement.
- Group 3 Other disease NM confirmed or to be confirmed.
- Group 4 control subjects.
- Exclusion Criteria:
- Patient presenting all pathologies judged by the investigator to interfere with the smooth running of the study (facial trauma, ...).
- Pregnant or breastfeeding women of childbearing age.
Exclusion
Key Trial Info
Start Date :
March 5 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 25 2019
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT04377217
Start Date
March 5 2019
End Date
July 25 2019
Last Update
November 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Pasteur 2
Nice, France, 06001